The NIH launched a $87 million Standardized Organoid Modeling Center to accelerate organoid research reproducibility, aiming to reduce reliance on animal testing. In parallel, artificial tissue organoids mimicking female reproductive organs promise breakthroughs for conditions like endometriosis and preeclampsia. These curated organoid platforms advance drug discovery and personalized medicine, reflecting a push toward regenerative solutions in biomedicine.